The world’s climate is in uncharted territory, warns major report
Meltwater runs off the Bråsvellbreen Glacier in the Norwegian archipelago of SvalbardSebnem Coskun/Anadolu via Getty Images Unprecedented levels of ocean ...
Flurry of worry over benefit changes
Arguments about benefits always revolve around a single concept: fairness.There are timeless questions – who is deserving and who is ...
Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy
(MedPage Today) -- Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single ...
Young Patient Dies After Receiving New Gene Therapy for Duchenne Muscular Dystrophy
(MedPage Today) -- A young person with Duchenne muscular dystrophy died following treatment with the recently approved gene therapy delandistrogene ...
Texas Midwife Accused by State’s Attorney General of Providing Illegal Abortions
(MedPage Today) -- A Texas midwife has been arrested and accused of providing illegal abortions, marking the first time authorities ...
Transplant Doc’s Future in U.S. Uncertain Following Her Deportation to Lebanon
(MedPage Today) -- The fate of a Brown University kidney transplant specialist hangs in limbo after she was deported on ...
This Vaccine Researcher Was Caught in the NIH Funding Cut Crossfire
(MedPage Today) -- The NIH has begun cancelling grant-funded research for dozens of projects studying ways to overcome vaccine hesitancy, ...
Snubbed Vaccine Committee Members Lament FDA’s Flu Shot Actions
(MedPage Today) -- Some current and past members of an FDA advisory committee felt snubbed when the agency went ahead ...
Investigational ADC Shows Promise in Advanced Endometrial Cancer
(MedPage Today) -- Puxitatug samrotecan (P-Sam), an investigational antibody-drug conjugate (ADC) targeting B7-H4-expressing tumors, showed promising efficacy in patients with ...
Experts Sound the Alarm on Pricey Skin Substitutes in Wound Care Industry
(MedPage Today) -- The runaway costs of skin substitutes for treating chronic wounds have experts and accountable care organizations (ACOs) ...
Daily Oral Islatravir and Doravirine Just as Effective as Other ART Regimens for HIV
(MedPage Today) -- SAN FRANCISCO -- Switching to islatravir and doravirine was just as effective as bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF; ...
Benefits crackdown unveiled with aim to save £5bn a year by 2030
Becky MortonPolitical reporterHouse of CommonsThe government has unveiled sweeping changes to the benefits system, aimed at saving £5bn a year ...
Supranormal EF; Cannabis Use and CVD; Cardiologist’s Sex Crime Accusations
(MedPage Today) -- Should heart failure with supranormal ejection fraction (EF) be considered separate from preserved ejection fraction? (Journal of ...
Future of Canadian Guidelines, Task Force in Doubt
Canada’s minister of health ordered a temporary pause in the work of the Canadian Task Force on Preventive Health Care ...
Belly Dancer’s Dyskinesia; Doomsday Clock and Alzheimer’s; Epstein-Barr and MS
(MedPage Today) -- A report detailed a case of belly dancer's dyskinesia after an acute corpus callosum infarction. (JAMA Neurology) ...
Myasthenia Gravis Antibody Types
(MedPage Today) -- Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major antibody categories: ...
Weird meteorite may be relic of lost planet that no longer exists
The NWA 15915 meteorite was discovered in 2023Steve Jurvetson/CC BY 2.0 Misfit meteorites that don’t fit neatly into known categories ...
Diabetes Study’s Funding Yanked; Marriage-Obesity Link; CVS ‘Menopause-Friendly’
(MedPage Today) -- Researchers for the ongoing 30-year Diabetes Prevention Program found out last week that the NIH canceled funding ...
Ultra-fast chargers can refill electric car batteries in minutes
How quickly can a public charging station fill up an electric car?Ralf Hahn/Getty Images Chinese car firm BYD has announced ...
Pembrolizumab-Olaparib Boosts PFS in Non-BRCA Ovarian Cancer
(MedPage Today) -- A first-line regimen involving pembrolizumab (Keytruda) and olaparib (Lynparza) significantly reduced the risk of disease progression or ...
